|
UTP11L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.661300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.557420E-03 |
| Normal-vs-Stage2 |
2.036200E-01 |
| Normal-vs-Stage3 |
2.624200E-02 |
| Normal-vs-Stage4 |
5.466400E-01 |
| Stage1-vs-Stage2 |
3.711400E-01 |
| Stage1-vs-Stage3 |
5.804600E-01 |
| Stage1-vs-Stage4 |
3.428200E-02 |
| Stage2-vs-Stage3 |
6.492600E-01 |
| Stage2-vs-Stage4 |
4.663000E-01 |
| Stage3-vs-Stage4 |
1.807600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.038500E-03 |
| Normal-vs-AfricanAmerican |
9.616400E-02 |
| Normal-vs-Asian |
3.903300E-03 |
| Caucasian-vs-AfricanAmerican |
7.996200E-01 |
| Caucasian-vs-Asian |
2.617800E-01 |
| AfricanAmerican-vs-Asian |
6.081400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.836300E-02 |
| Normal-vs-Female |
3.682200E-03 |
| Male-vs-Female |
7.230400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.364190E-03 |
| Normal-vs-Age(41-60Yrs) |
5.397700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.244600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.000800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.121990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.228200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.187200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.156800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.224570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.668000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.821360E-01 |
| Classical-VS-Follicular |
3.203600E-03 |
| Classical-VS-Other |
1.614020E-01 |
| Classical-VS-Normal |
1.026800E-04 |
| Tall-VS-Follicular |
4.670000E-01 |
| Tall-VS-Other |
5.130200E-01 |
| Tall-VS-Normal |
2.119200E-01 |
| Follicular-VS-Other |
8.544200E-01 |
| Follicular-VS-Normal |
7.080000E-01 |
| Other-VS-Normal |
9.480800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.568200E-02 |
| Normal-vs-N1 |
4.200200E-02 |
| N0-vs-N1 |
6.331800E-01 |
|
|
